Germline BRCA2 mutations have especially been associated with a poor prognosis and have been found to be an independent prognostic factor for PCa patients [38,39], and this applies even in cases with a limited tumor volume and low histopathological grade [24]. Here, BRCA2 is linked to neoplasm.